Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency

被引:2
|
作者
Nishimura, Masashi
Miyata, Jun [1 ]
Tanigaki, Tomomi
Nomura, Sakika
Serizawa, Yusuke
Igarashi, Syunya
Itou, Koki
Ohno, Tomohiro
Kurata, Yuhei
Kimizuka, Yoshifumi
Fujikura, Yuji
Sekinaka, Yujin
Sekinaka, Kanako
Matsukuma, Susumu
Nonoyama, Shigeaki
Kawana, Akihiko
机构
[1] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Resp Med, Tokorozawa, Japan
关键词
common variable immunodeficiency; corticosteroid; CTLA-4; deficiency; granulomatous-lymphocytic interstitial lung disease; video-assisted thoracoscopic surgery; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS;
D O I
10.2169/internalmedicine.0076-22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Common variable immunodeficiency (CVID) causes granulomatous-lymphocytic interstitial lung disease (GLILD) and has a poor prognosis. We herein report a case of GLILD in a 49-year-old woman with CTLA-4 deficiency-associated CVID. The patient presented with dyspnea that had worsened over the past two years. A laboratory examination revealed hypoglobulinemia and pancytopenia. Chest computed tomography showed diffuse infiltrative and granular shadows in the bilateral interstitium. A flow cytometric analysis of blood cells and genetic testing confirmed CTLA-4 deficiency. We performed video-assisted thoracoscopic surgery for the pathological diagnosis of GLILD and to exclude infection and malignancy. Corticosteroid treatment successfully improved the condition of the patient.
引用
收藏
页码:871 / 875
页数:5
相关论文
共 50 条
  • [21] Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
    Mai Sasaki Aanensen Fraz
    Annika Elisabet Michelsen
    Natasha Moe
    Trond Mogens Aaløkken
    Magnhild Eide Macpherson
    Ingvild Nordøy
    Pål Aukrust
    Eli Taraldsrud
    Are Martin Holm
    Thor Ueland
    Silje Fjellgård Jørgensen
    Børre Fevang
    Journal of Clinical Immunology, 2022, 42 : 1553 - 1563
  • [22] Granulomatous interstitial nephritis with CTLA-4 haploinsufficiency: a case report
    Kohatsu, Kaori
    Suzuki, Tomo
    Takimoto, Madoka
    Matsui, Katsuomi
    Hashiguchi, Akinori
    Koike, Junki
    Shirai, Sayuri
    BMC NEPHROLOGY, 2022, 23 (01)
  • [23] Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
    Fraz, Mai Sasaki Aanensen
    Michelsen, Annika Elisabet
    Moe, Natasha
    Aalokken, Trond Mogens
    Macpherson, Magnhild Eide
    Nordoy, Ingvild
    Aukrust, Pal
    Taraldsrud, Eli
    Holm, Are Martin
    Ueland, Thor
    Jorgensen, Silje Fjellgard
    Fevang, Borre
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (07) : 1553 - 1563
  • [24] The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease
    Smits, Bas
    Goldacker, Sigune
    Seneviratne, Suranjith
    Malphettes, Marion
    Longhurst, Hilary
    Mohamed, Omar E.
    Witt-Rautenberg, Carla
    Leeman, Lucy
    Schwaneck, Eva
    Raymond, Isabelle
    Meghit, Kilifa
    Uhlmann, Annette
    Winterhalter, Christine
    van Montfrans, Joris
    Klima, Marion
    Workman, Sarita
    Fieschi, Claire
    Lorenzo, Lorena
    Boyle, Sonja
    Onyango-Odera, Shamin
    Price, Suzanne
    Schmalzing, Marc
    Aurillac, Valerie
    Prasse, Antje
    Hartmann, Ieneke
    Meerburg, Jennifer J.
    Kemner-van de Corput, Mariette
    Tiddens, Harm
    Grimbacher, Bodo
    Kelleher, Peter
    Patel, Smita Y.
    Korganow, Anne-Sophie
    Viallard, Jean-Francois
    Tony, Hans-Peter
    Bethune, Claire
    Schulze-Koops, Hendrik
    Witte, Torsten
    Huissoon, Aarnoud
    Baxendale, Helen
    Grigoriadou, Sofia
    Oksenhendler, Eric
    Burns, Siobhan O.
    Warnatz, Klaus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 152 (02) : 528 - 537
  • [25] Granulomatous Lymphocytic Interstitial Lung Disease in a Spectrum of Pediatric Primary Immunodeficiencies
    Szczawinska-Poplonyk, Aleksandra
    Jonczyk-Potoczna, Katarzyna
    Mikos, Marcin
    Ossowska, Lidia
    Langfort, Renata
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2021, 24 (06) : 504 - 512
  • [26] Case Report: Common variable immunodeficiency phenotype and granulomatous-lymphocytic interstitial lung disease with a novel SOCS1 variant
    Caldirola, Maria Soledad
    Daiana, Espantoso
    Gomez Raccio, Andrea Cecilia
    Garcia, Ana Luz
    Bernacchia, Agustin
    Medin, Martin
    Gaillard, Maria Isabel
    Di Giovanni, Daniela
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [27] Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency
    Tessarin, G.
    Bondioni, M. P.
    Rossi, S.
    Palumbo, L.
    Soresina, A.
    Badolato, R.
    Plebani, A.
    Lougaris, V
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (06) : 470 - 471
  • [28] Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells
    Deya-Martinez, Angela
    Esteve-Sole, Ana
    Velez-Tirado, Natalia
    Celis, Veronica
    Costa, Jordi
    Cols, Maria
    Jou, Cristina
    Vlagea, Alexandru
    Maria Plaza-Martin, Ana
    Juan, Manel
    Alsina, Laia
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (04) : 425 - 432
  • [29] FDG-Avid Granulomatous Lymphocytic Interstitial Lung Disease With Common Variable Immunodeficiency
    van der Zant, Friso M.
    Knol, Remco J. J.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1062 - 1063
  • [30] X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis
    Steele, Cathal L.
    Dore, Matthew
    Ammann, Sandra
    Loughrey, Maurice
    Montero, Angeles
    Burns, Siobhan O.
    Morris, Emma C.
    Gaspar, Bobby
    Gilmour, Kimberly
    Bibi, Shahnaz
    Shendi, Hiba
    Devlin, Lisa
    Speckmann, Carsten
    Edgar, David M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (07) : 733 - 738